Improved Survival Among Patients With Eisenmenger Syndrome Receiving Advanced Therapy for Pulmonary Arterial Hypertension
Open Access
- 5 January 2010
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Circulation
- Vol. 121 (1), 20-25
- https://doi.org/10.1161/circulationaha.109.883876
Abstract
Background— Advanced therapy (AT) for pulmonary arterial hypertension in the context of congenital heart disease (Eisenmenger syndrome) improves pulmonary hemodynamics, functional class, and the 6-minute walk test. We examined the potential effect of AT on survival in this population. Methods and Results— Data on all Eisenmenger patients attending our center over the past decade were collected. Survival rates were compared between patients on and off AT with the use of a modified version of the Cox model, which treats AT as a time-varying covariate. Baseline differences were adjusted for the use of propensity scores. A total of 229 patients (aged 34.5±12.6 years; 35.4% male) were included. The majority had complex anatomy, and 53.7% were in New York Heart Association class ≥III at baseline assessment. Mean resting saturations were 84.3%. Sixty-eight patients (29.7%) either were on AT or had AT initiated during follow-up. During a median follow-up of 4.0 years, 52 patients died, only 2 of them while on AT. Patients on AT were at a significantly lower risk of death, both unadjusted and after adjustment for baseline clinical differences by propensity score regression adjustment ( C statistic=0.80; hazard ratio, 0.16; 95% confidence interval, 0.04 to 0.71; P =0.015) and propensity score matching (hazard ratio, 0.10; 95% confidence interval, 0.01 to 0.78; P =0.028). Conclusions— AT for pulmonary arterial hypertension in a contemporary cohort of adults with Eisenmenger syndrome was associated with a lower risk of death. Survival benefits should be considered together with improved hemodynamics and functional class when decisions are made about AT in this population.This publication has 26 references indexed in Scilit:
- A meta-analysis of randomized controlled trials in pulmonary arterial hypertensionEuropean Heart Journal, 2008
- Prevalence, Predictors, and Prognostic Value of Renal Dysfunction in Adults With Congenital Heart DiseaseCirculation, 2008
- Heart–lung and lung transplantation in grown-up congenital heart disease: long-term single centre experience☆European Journal of Cardio-Thoracic Surgery, 2007
- Effects of chronic sildenafil in patients with Eisenmenger syndrome versus idiopathic pulmonary arterial hypertensionInternational Journal of Cardiology, 2007
- European PerspectivesCirculation, 2007
- Bosentan Therapy in Patients With Eisenmenger SyndromeCirculation, 2006
- Abnormal Ventilatory Response to Exercise in Adults With Congenital Heart Disease Relates to Cyanosis and Predicts SurvivalCirculation, 2006
- Advanced therapy may delay the need for transplantation in patients with the Eisenmenger syndromeEuropean Heart Journal, 2006
- Treatment of Pulmonary Arterial HypertensionThe New England Journal of Medicine, 2004
- The Eisenmenger Syndrome: IIBMJ, 1958